Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.810
+0.030 (1.69%)
Nov 4, 2024, 12:44 PM EST - Market open
Heron Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -48.13 | -110.56 | -182.02 | -220.68 | -227.28 | -204.75 | Upgrade
|
| Depreciation & Amortization | 2.77 | 2.9 | 2.89 | 3.02 | 2.85 | 2.04 | Upgrade
|
| Other Amortization | 0.52 | 0.34 | 0.2 | 0.9 | 1.43 | 1.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | 0.01 | 0.07 | 0.82 | - | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.75 | 0.62 | 0.21 | 0.48 | 0.85 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.12 | -1.74 | -0.74 | 0.33 | 0.13 | -3.74 | Upgrade
|
| Stock-Based Compensation | 18.95 | 32.85 | 42.98 | 46.85 | 50.22 | 51.41 | Upgrade
|
| Change in Accounts Receivable | 2.99 | -8.09 | -16.55 | 6.35 | -1.97 | 24.77 | Upgrade
|
| Change in Inventory | 1.76 | 12.46 | -6.19 | -6.48 | -16.94 | 14.06 | Upgrade
|
| Change in Accounts Payable | 8.27 | 0.02 | -0.58 | 3.28 | -2.23 | -14.11 | Upgrade
|
| Change in Other Net Operating Assets | -9.6 | 12.4 | 12.81 | -38.23 | 8.13 | 4.5 | Upgrade
|
| Operating Cash Flow | -20.84 | -58.79 | -146.91 | -203.35 | -184.82 | -124.58 | Upgrade
|
| Capital Expenditures | -1.68 | -1.55 | -1.83 | -3.02 | -6.81 | -7.15 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.23 | 0.03 | - | - | Upgrade
|
| Investment in Securities | -27.06 | 19.53 | -1.73 | 35.72 | 215.77 | -14.63 | Upgrade
|
| Investing Cash Flow | -28.73 | 18 | -3.32 | 32.73 | 208.96 | -21.78 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.03 | - | Upgrade
|
| Long-Term Debt Issued | - | 24.35 | - | 148.96 | - | - | Upgrade
|
| Total Debt Issued | 24.35 | 24.35 | - | 148.96 | 0.03 | - | Upgrade
|
| Net Debt Issued (Repaid) | 24.35 | 24.35 | - | 148.96 | 0.03 | - | Upgrade
|
| Issuance of Common Stock | 30.46 | 30.66 | 76.59 | 7.07 | 9.08 | 186.43 | Upgrade
|
| Other Financing Activities | -0.31 | -0.9 | -1.53 | - | - | - | Upgrade
|
| Financing Cash Flow | 54.5 | 54.11 | 75.06 | 156.03 | 9.11 | 186.43 | Upgrade
|
| Net Cash Flow | 4.92 | 13.31 | -75.18 | -14.6 | 33.24 | 40.06 | Upgrade
|
| Free Cash Flow | -22.52 | -60.33 | -148.74 | -206.38 | -191.63 | -131.73 | Upgrade
|
| Free Cash Flow Margin | -16.52% | -47.49% | -138.14% | -239.01% | -216.20% | -90.25% | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -0.44 | -1.37 | -2.10 | -2.11 | -1.61 | Upgrade
|
| Cash Interest Paid | 4.36 | 3.06 | 2.25 | 1.24 | - | - | Upgrade
|
| Levered Free Cash Flow | 0.29 | -16.84 | -75.81 | -103.97 | -106.92 | -56.76 | Upgrade
|
| Unlevered Free Cash Flow | 3.25 | -14.76 | -74.46 | -103.37 | -107.16 | -56.89 | Upgrade
|
| Change in Net Working Capital | -1.2 | -9.17 | 12.72 | 14.95 | 14.32 | -28.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.